Skip to main content

Compare Stocks

Date Range: 

 MediciNovaCorbus PharmaceuticalsPLx PharmaCerecorHarrow Health
SymbolNASDAQ:MNOVNASDAQ:CRBPNASDAQ:PLXPNASDAQ:CERCNASDAQ:HROW
Price Information
Current Price$4.09$1.59$11.17$2.23$9.34
52 Week RangeBuyHoldBuyBuyBuy
MarketRank™
Overall Score1.21.71.51.81.4
Analysis Score3.53.23.33.53.5
Community Score2.73.02.12.92.1
Dividend Score0.00.00.00.00.0
Ownership Score0.01.71.72.50.8
Earnings & Valuation Score0.00.60.60.00.6
Analyst Ratings
Consensus RecommendationBuyHoldBuyBuyBuy
Consensus Price Target$13.00$15.69$16.00$7.50$15.00
% Upside from Price Target217.85% upside886.64% upside43.24% upside236.32% upside60.60% upside
Trade Information
Market Cap$202.88 million$198.80 million$255.12 million$210.01 million$238.71 million
Beta1.42.145.031.671.08
Average Volume709,87810,707,807249,3471,674,617235,478
Sales & Book Value
Annual RevenueN/A$36.14 million$570,000.00$6.75 million$51.17 million
Price / SalesN/A5.50447.5831.544.85
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book Value$1.71 per share$0.10 per share($1.32) per share$0.40 per share$1.09 per share
Price / BookN/A15.90-8.465.588.57
Profitability
Net Income$-12,940,000.00$-71,450,000.00$-20,500,000.00$-16,070,000.00$170,000.00
EPSN/A($1.12)($4.74)($0.30)($0.29)
Trailing P/E Ratio0.00N/AN/AN/AN/A
Forward P/E RatioN/AN/AN/AN/A33.36
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/A-2,208.06%-4,906.25%-799.40%-3.94%
Return on Equity (ROE)-17.56%-485.45%N/A-93.78%-3.52%
Return on Assets (ROA)-16.62%-167.68%-90.31%-61.01%-1.36%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/A0.61%N/AN/A0.53%
Current Ratio34.68%2.06%2.52%2.48%2.97%
Quick Ratio34.68%2.06%2.49%2.48%2.68%
Ownership Information
Institutional Ownership Percentage21.65%67.13%22.46%66.41%44.37%
Insider Ownership Percentage16.00%8.20%9.42%58.00%12.43%
Miscellaneous
Employees976830125
Shares Outstanding48.77 million125.03 million22.84 million95.46 million26.58 million
Next Earnings Date7/27/2021 (Estimated)5/17/2021 (Estimated)8/13/2021 (Estimated)8/5/2021 (Estimated)8/9/2021 (Estimated)
OptionableOptionableOptionableNot OptionableOptionableOptionable
SourceHeadline
Harrow reports record Q1, to launch telehealth platform this weekHarrow reports record Q1, to launch telehealth platform this week
nashvillepost.com - May 12 at 6:42 PM
Harrow Health (NASDAQ:HROW) Releases Quarterly  Earnings Results, Misses Expectations By $0.03 EPSHarrow Health (NASDAQ:HROW) Releases Quarterly Earnings Results, Misses Expectations By $0.03 EPS
americanbankingnews.com - May 12 at 2:12 PM
Mid-Day Market Update: Array Technologies Drops Following Downbeat Earnings; Harrow Health Shares ClimbMid-Day Market Update: Array Technologies Drops Following Downbeat Earnings; Harrow Health Shares Climb
benzinga.com - May 12 at 1:41 PM
Harrow Health (NASDAQ:HROW) Earns "Buy" Rating from B. RileyHarrow Health (NASDAQ:HROW) Earns "Buy" Rating from B. Riley
americanbankingnews.com - May 12 at 10:24 AM
Harrow: Q1 Earnings SnapshotHarrow: Q1 Earnings Snapshot
sfgate.com - May 11 at 6:04 PM
Harrow Health Announces Record First Quarter 2021 Financial ResultsHarrow Health Announces Record First Quarter 2021 Financial Results
finance.yahoo.com - May 11 at 6:04 PM
Harrow raises $66MHarrow raises $66M
nashvillepost.com - May 7 at 3:22 PM
Harrow Health Announces Full Exercise and Closing of Option to Purchase Additional Senior NotesHarrow Health Announces Full Exercise and Closing of Option to Purchase Additional Senior Notes
markets.businessinsider.com - May 5 at 6:07 PM
Harrow Health Announces Full Exercise and Closing of Option to Purchase Additional Senior NotesHarrow Health Announces Full Exercise and Closing of Option to Purchase Additional Senior Notes
finance.yahoo.com - May 5 at 6:07 PM
Harrow Health Raises Approximately $11 Million in Sale of Series B Preferred StockHarrow Health Raises Approximately $11 Million in Sale of Series B Preferred Stock
finance.yahoo.com - May 5 at 6:07 PM
Will Harrow Health (HROW) Report Negative Earnings Next Week? What You Should KnowWill Harrow Health (HROW) Report Negative Earnings Next Week? What You Should Know
finance.yahoo.com - May 4 at 8:06 PM
Harrow Health (NASDAQ:HROW) Releases Q1 2021 Earnings GuidanceHarrow Health (NASDAQ:HROW) Releases Q1 2021 Earnings Guidance
americanbankingnews.com - May 4 at 5:40 PM
Harrow Health (HROW) to Release Earnings on TuesdayHarrow Health (HROW) to Release Earnings on Tuesday
americanbankingnews.com - May 4 at 5:48 AM
Harrow Health to Announce First Quarter 2021 Financial Results on May 11, 2021Harrow Health to Announce First Quarter 2021 Financial Results on May 11, 2021
finance.yahoo.com - April 27 at 12:45 PM
We Think Harrow Health (NASDAQ:HROW) Is Taking Some Risk With Its DebtWe Think Harrow Health (NASDAQ:HROW) Is Taking Some Risk With Its Debt
nasdaq.com - April 21 at 7:42 AM
Harrow Health Announces Closing of $50 Million Offering of Senior Notes Due 2026Harrow Health Announces Closing of $50 Million Offering of Senior Notes Due 2026
finance.yahoo.com - April 20 at 7:44 PM
Harrow Health, Inc. (NASDAQ:HROW) Has Recovered 54.63% So Far, But Another 38.75% Gain Cannot Be Ruled OutHarrow Health, Inc. (NASDAQ:HROW) Has Recovered 54.63% So Far, But Another 38.75% Gain Cannot Be Ruled Out
marketingsentinel.com - April 17 at 8:17 AM
Harrow Health offers $25M of senior notes due 2026Harrow Health offers $25M of senior notes due 2026
seekingalpha.com - April 16 at 7:35 AM
Harrow Health Announces Pricing of $50 Million Offering of Senior Notes Due 2026Harrow Health Announces Pricing of $50 Million Offering of Senior Notes Due 2026
finance.yahoo.com - April 15 at 6:55 PM
Do Insiders Own Lots Of Shares In Harrow Health, Inc. (NASDAQ:HROW)?Do Insiders Own Lots Of Shares In Harrow Health, Inc. (NASDAQ:HROW)?
finance.yahoo.com - April 5 at 11:17 AM
Harrow Health, Inc.s (HROW) CEO Mark Baum on Q4 2020 Results - Earnings Call TranscriptHarrow Health, Inc.'s (HROW) CEO Mark Baum on Q4 2020 Results - Earnings Call Transcript
seekingalpha.com - March 10 at 12:38 PM
Harrow: Q4 Earnings SnapshotHarrow: Q4 Earnings Snapshot
finance.yahoo.com - March 8 at 7:20 PM
Harrow Health Announces Fourth Quarter and Year-End 2020 Financial ResultsHarrow Health Announces Fourth Quarter and Year-End 2020 Financial Results
finance.yahoo.com - March 8 at 7:20 PM
Harrow Health (HROW) Lags Q4 Earnings EstimatesHarrow Health (HROW) Lags Q4 Earnings Estimates
finance.yahoo.com - March 8 at 7:20 PM
Harrow Health to Participate in H.C. Wainwright Global Life Sciences ConferenceHarrow Health to Participate in H.C. Wainwright Global Life Sciences Conference
finance.yahoo.com - March 2 at 12:28 PM
DateCompanyBrokerageAction
3/16/2021MediciNovaMaxim GroupInitiated Coverage
8/3/2020MediciNovaB. RileyReiterated Rating
3/16/2021Corbus PharmaceuticalsOppenheimerReiterated Rating
10/8/2020Corbus PharmaceuticalsHC WainwrightLower Price Target
9/8/2020Corbus PharmaceuticalsJefferies Financial GroupDowngrade
9/8/2020Corbus PharmaceuticalsRoyal Bank of CanadaDowngrade
9/8/2020Corbus PharmaceuticalsBTIG ResearchDowngrade
9/8/2020Corbus PharmaceuticalsRoth CapitalDowngrade
6/4/2020Corbus PharmaceuticalsNomuraBoost Price Target
6/4/2020Corbus PharmaceuticalsNomura InstinetBoost Price Target
3/26/2020Corbus PharmaceuticalsNomura SecuritiesInitiated Coverage
3/20/2019Corbus PharmaceuticalsCIBCInitiated Coverage
3/1/2021PLx PharmaJMP SecuritiesBoost Price Target
8/14/2020PLx PharmaRaymond JamesReiterated Rating
4/12/2019PLx PharmaJanney Montgomery ScottInitiated Coverage
6/7/2020CerecorLADENBURG THALM/SH SHReiterated Rating
8/16/2019Harrow HealthLake Street CapitalSet Price Target
(Data available from 5/17/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.